Management of ASC-US with Positive HPV

Primary Management Algorithm

The American College of Obstetricians and Gynecologists recommends that women aged ≥21 years with ASC-US cytology and positive high-risk HPV testing should undergo immediate colposcopy, as this combination carries a 9.7% risk of CIN 2+ in non-adolescent women and up to 20% risk in some studies 1, 2
The risk of high-grade histological changes (CIN 2 or higher) is significantly elevated when HPV is positive compared to HPV-negative ASC-US, making immediate evaluation critical 1
HPV positivity in women ≥30 years is particularly concerning as it is less likely to represent transient infection and warrants immediate colposcopic referral 1

Endocervical sampling is preferred when no lesions are identified and in cases of unsatisfactory colposcopy, according to the American Journal of Obstetrics and Gynecology 3
If colposcopy identifies CIN 2+, proceed with appropriate treatment according to standard protocols 1
Colposcopic biopsy should be performed on any lesions suspicious for CIN 2,3, as recommended by the American Academy of Family Physicians 4

For women with HPV-positive ASC-US in whom CIN is not identified at colposcopy, HPV DNA testing at 12 months is the preferred option, according to the American Journal of Obstetrics and Gynecology 3
Repeat cytology at 6-month and 12-month intervals until two consecutive negative results are obtained is an alternative option, as recommended by the Centers for Disease Control and Prevention 2, 3

For adolescents (age ≤20 years), HPV testing is unacceptable, and follow-up with annual cytology testing is recommended instead, according to the American Journal of Obstetrics and Gynecology 3
For women 21-29 years, colposcopy is recommended for HPV-positive ASC-US, and the standard management algorithm applies, as recommended by the American College of Obstetricians and Gynecologists 1
For women ≥30 years, immediate colposcopy is strongly recommended due to higher risk of significant disease, according to the American College of Obstetricians and Gynecologists 1

For HIV-infected women, more conservative management is recommended, with immediate colposcopy for ASC-US regardless of HPV status, as recommended by the Centers for Disease Control and Prevention 5
For pregnant women, management options are identical to non-pregnant women over age 20, and colposcopy may be deferred until at least 6 weeks postpartum if preferred, according to the American Journal of Obstetrics and Gynecology 3

Never delay colposcopy in HPV-positive ASC-US cases in women over 30, as this increases risk of missed high-grade disease, according to the American College of Obstetricians and Gynecologists 1
Do not rely on repeat cytology alone for HPV-positive ASC-US in women over 30, as it has significantly lower sensitivity than immediate colposcopy, according to the American College of Obstetricians and Gynecologists 1
Avoid unnecessary colposcopy for ASC-US with negative high-risk HPV, as this leads to overtreatment, according to the American College of Obstetricians and Gynecologists 1

The American College of Obstetricians and Gynecologists and American Society for Colposcopy and Cervical Pathology recommend HPV testing as the primary triage method for ASC-US in women ≥21 years, with a high negative predictive value of 98.5-99.6% for excluding high-grade lesions 6, 7

Punch biopsy is performed during colposcopy when abnormal areas are identified, not as a standalone procedure, and is only indicated after determining HPV status and performing colposcopy if indicated, as recommended by the American College of Obstetrics and Gynecology 6, 7